BioPharma Resources

Drug Trial Radar · NCT06930625

A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs

A Phase 3 Randomized 3-arm Trial (Double-blind Debio 4126, Placebo Control, and Open-label Debio 4126), to Assess the Efficacy and Safety of Debio 4126, a 12-week Octreotide Formulation, in Patients With Acromegaly Previously Treated With Somatostatin Analogs

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 119 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

119

Planned (sponsor's estimate)

Start

Nov 26, 2025

Primary completion

Jun 2028

Study completion Mar 2029

Sponsor

Lead sponsor
Debiopharm International SAIndustry
Sponsor type
Industry
First posted
Apr 16, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, care provider)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of this study is to assess the effect of Debio 4126 in the maintenance of the levels of insulin-like growth factor 1 (IGF-1) ≤1x upper limit of normal (ULN) in the double-blind period (Period 1) in comparison to placebo at week 36.

Conditions

  • Acromegaly

Interventions

  • Debio 4126Drug

    IM injection, a 12-week extended-release formulation of octreotide

  • PlaceboDrug

    IM injection of mannitol suspension

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Double-blind Period: Percentage of Participants With IGF-1 ≤1x ULNTime frame: 36 Weeks

Locations

74 sites in 21 countries. Site status is shown where the registry gives one.

  • Cedars Sinai Medical Center

    Los Angeles, California · Recruiting

  • Northwestern University

    Chicago, Illinois · Recruiting

  • Harvard Medical School

    Boston, Massachusetts · Recruiting

  • Washington University-School of Medicine

    St Louis, Missouri · Recruiting

  • Palm Research Center Inc

    Las Vegas, Nevada · Recruiting

  • NYU Grossman School of Medicine

    New York, New York · Recruiting

  • The Cleveland Clinic

    Cleveland, Ohio · Recruiting

  • The Ohio State University

    Columbus, Ohio · Recruiting

  • Oregon Health & Science University

    Portland, Oregon · Recruiting

  • Thomas Jefferson University

    Philadelphia, Pennsylvania · Recruiting

  • Medical University Graz

    Graz, Austria · Recruiting

  • Medizinische Universitaet Wien - Division of Endocrinology and Metabolism

    Vienna, Austria · Recruiting

  • UZ Gent

    Ghent, Belgium · Recruiting

  • Hospital Medical Center L2

    Brasília, Brazil · Recruiting

  • CETI - Centro de Estudos em Terapias Inovadoras

    Curitiba, Brazil · Recruiting

  • Nucleo de Pesquisa e Desenvolvimento de Medicamentos (NPDM)

    Fortaleza, Brazil · Recruiting

  • Hospital das Clinicas da UFMG

    Minas Gerais, Brazil · Recruiting

  • Instituto Estadual do Cérebro Paulo Niemeyer (IECPN)

    Rio de Janeiro, Brazil · Recruiting

  • Hospital das Clinicas - University of Sao Paulo Medical School

    São Paulo, Brazil · Recruiting

  • University Specialized Hospital for Active Treatment of Endocrinology Akad. lv Penchev EAD

    Sofia, Bulgaria · Recruiting

  • Rigshospitalet, Blegdamsvej 9

    Copenhagen, Denmark · Recruiting

  • Zealand University Hospital

    Køge, Denmark · Recruiting

  • East Tallinn Central Hospital

    Tallinn, Estonia · Recruiting

  • North Estonia Medical Centre Foundation

    Tallinn, Estonia · Recruiting

  • CHU d'Angers

    Angers, France · Recruiting

  • Hospices Civils de Lyon

    Bron, France · Recruiting

  • APHP - Hôpital Bicêtre

    Le Kremlin-Bicêtre, France · Recruiting

  • Assistance Publique Hopitaux de Marseille (AP-HM) - Hopital La Conception

    Marseille, France · Recruiting

  • Hopital Haut-Leveque

    Pessac, France · Recruiting

  • CHU Toulouse - Hôpital Larrey

    Toulouse, France · Recruiting

  • Charité Universitätsmedizin Berlin

    Berlin, Germany · Recruiting

  • Klinikum der Universität München Medizinische Klinik und Poliklinik IV - Zi

    Munich, Germany · Recruiting

  • Universitätsklinikum Würzburg - Poliklinik I - Endokrinologie u. Diabetolog

    Würzburg, Germany · Recruiting

  • Semmelweis Egyetem, Belgyogyaszati es Onkologiai Klinika

    Budapest, Hungary · Recruiting

  • Eszak-Pesti Centrumkorhaz-Honvedkorhaz Endokrinologia

    Budapest, Hungary · Recruiting

  • University of Szeged Faculty of Medicine

    Szeged, Hungary · Recruiting

  • Bnai Zion Medical Center

    Haifa, Israel · Recruiting

  • Rambam Health Care Campus

    Haifa, Israel · Recruiting

  • Rabin Medical Center - Beilinson Campus

    Petah Tikva, Israel · Recruiting

  • Tel Aviv Sourasky Medical Center

    Tel Aviv, Israel · Recruiting

Showing 40 of 74 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.